-
BostonGene Announces Partnership with National Institutes of Health
Post on 7/23/19
-
Samus Therapeutics Launches PU-AD Clinical Program in Alzheimer's Disease
Post on 7/23/19
-
Frequency Therapeutics Completes $62 Million Series C Financing
Post on 7/23/19
-
Ra Pharmaceuticals Proposes Public Offering of Common Stock
Post on 7/22/19
-
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 7/21/19
-
AVROBIO Closes Underwritten Public Offering
Post on 7/21/19
-
Fulcrum Therapeutics Prices IPO
Post on 7/18/19
-
Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities
Post on 7/18/19
-
NeuroMetrix Reports Q2 2019 Financial Results
Post on 7/18/19
-
Bioasis Announces Stock Option Grants
Post on 7/17/19
-
Cigna and Express Scripts Named Best Places to Work for Disability Inclusion
Post on 7/17/19
-
Tufts Health Plan Named a Best Place to Work for Disability Inclusion
Post on 7/17/19
-
Pandion Therapeutics Appoints Rahul Kakkar as CEO
Post on 7/17/19
-
Orum Therapeutics Announces $30 Million Series B
Post on 7/17/19
-
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322
Post on 7/17/19
-
ImmunoGen: Bold Move To Position A Comeback
Post on 7/17/19
-
Cara Therapeutics: Wait For A Better Entry Opportunity
Post on 7/17/19
-
AVROBIO Prices Underwritten Public Offering of $120.25 Million of Common Stock
Post on 7/16/19
-
HealthBanks Partners with athenahealth's Marketplace Program
Post on 7/16/19
-
Skyhawk Therapeutics Announces Agreement with Genentech
Post on 7/16/19
-
Ra Pharmaceuticals and Camurus Announce Exclusive License Agreement
Post on 7/16/19
-
Boston Children’s Hospital Forms Strategic Partnership with Premier
Post on 7/15/19
-
Nine Tech Startups Vie for Partnerships & Scale in MetLife’s Intensive 13-week Business ‘Boot Camp’
Post on 7/15/19
-
Poxel Provides Corporate Update
Post on 7/15/19
-
KalVista Pharmaceuticals Provides Operational Update
Post on 7/15/19